NASDAQ: KRYS - Krystal Biotech, Inc.

Lønnsomhet i seks måneder: +2.77%
Sektor: Healthcare

Kampanjeplan Krystal Biotech, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Krystal Biotech, Inc., биотехнологическая компания клинической стадии, занимается генной терапией повторного применения для лечения серьезных редких заболеваний в Соединенных Штатах. Его ведущим продуктом-кандидатом является беремаген геперпавек (B-VEC), который находится в фазе III клинических исследований по лечению дистрофического буллезного эпидермолиза.

Flere detaljer
Компания также участвует в разработке препарата KB105, который находится в стадии I/II клинических исследований для лечения пациентов с дефицитным аутосомно-рецессивным врожденным ихтиозом; KB301, который находится на клинической стадии фазы I/II для лечения морщин и других проявлений стареющей или поврежденной кожи; KB407, который находится на доклинической стадии муковисцидоза; и KB104, который находится на доклинической стадии для синдрома Нетертона. Его кандидаты на продукты на стадии открытия включают KB5xx для лечения хронических кожных заболеваний, KB3xx для лечения эстетических состояний кожи и продукт KB3xx. Krystal Biotech, Inc. была основана в 2015 году и имеет штаб-квартиру в Питтсбурге, штат Пенсильвания.

Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

EBITDA -0.0213
EV/EBITDA -35.82
Див.доход ао 0
Цена ао 168.44
Сайт https://www.krystalbio.com
ISIN US5011471027
P/BV 4.67
Число акций ао 0.02775 млрд
Выручка 0.0507
P/S 69.56
P/E 322.58
Валюта usd
IPO date 2017-09-20
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Prisendring per dag: -6.45% (180.13)
Prisendring per uke: -2.02% (171.98)
Prisendring per måned: -13.26% (194.27)
Prisendring over 3 måneder: -16.09% (200.83)
Prisendring over seks måneder: +2.77% (163.97)
Prisendring per år: +49.22% (112.93)
Prisendring over 3 år: +226.57% (51.6)
Prisendring over 5 år: +281.68% (44.15)
Prisendring siden begynnelsen av året: +61.78% (104.16)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 67.78 1
P/BV 4.41 4
P/E 314.35 1
EV/EBITDA -33.47 0
Total: 3.13

Effektivitet

Navn Betydning Karakter
ROA, % 1.34 1
ROE, % 1.4 1
Total: 1.5

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0878 10
Total: 8.4

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 4969.9 10
Lønnsomhet Ebitda, % 402.84 10
Lønnsomhet EPS, % -132.82 0
Total: 6
Flere detaljer

Transaksjonsdato Avsløringsdato Insider Type Pris Volum Mengde Del opp til, % Del etterpå, % Dokument
11.06.2024 11.06.2024 Krishnan Krish S
President and CEO		 Salg 175.76 4 394 000 25000 0 -0.1 link
11.06.2024 11.06.2024 Krishnan Suma
President, R&D		 Salg 175.77 4 394 250 25000 0 -0.1 link
28.02.2024 01.03.2024 Krishnan Krish S
President and CEO		 Kjøpe 168.66 1 264 950 7500 0 0.03 link
28.02.2024 01.03.2024 Krishnan Krish S
President and CEO		 Kjøpe 168.66 2 108 250 12500 0 0.05 link
28.02.2024 01.03.2024 Krishnan Suma
President, R&D		 Kjøpe 168.66 2 108 250 12500 0 0.05 link
28.02.2024 01.03.2024 Krishnan Suma
President, R&D		 Kjøpe 168.66 1 264 950 7500 0 0.03 link
28.02.2024 01.03.2024 Romano Kathryn
Chief Accounting Officer		 Salg 166.05 1 245 380 7500 0 -0.03 link
28.02.2024 01.03.2024 Romano Kathryn
Chief Accounting Officer		 Kjøpe 63.55 476 625 7500 0 0.03 link
28.02.2024 01.03.2024 Romano Kathryn
Chief Accounting Officer		 Salg 165.88 829 400 5000 0 -0.02 link
28.02.2024 01.03.2024 Romano Kathryn
Chief Accounting Officer		 Kjøpe 31.77 317 700 10000 0 0.04 link
09.06.2023 09.06.2023 ORTH ANDREW C.
Chief Commercial Officer		 Salg 128.61 1 607 620 12500 0 -0.05 link
09.06.2023 09.06.2023 ORTH ANDREW C.
Chief Commercial Officer		 Kjøpe 63.55 794 375 12500 0 0.05 link
09.06.2023 09.06.2023 JANNEY DANIEL
Director		 Salg 128.77 2 438 260 18935 0 -0.08 link
08.06.2023 09.06.2023 JANNEY DANIEL
Director		 Salg 128.11 3 979 740 31065 0 -0.12 link

Institusjoner Volum Dele, %
Avoro Capital Advisors LLC 2565555 9
Vanguard Group Inc 2435774 8.54
FMR, LLC 2385898 8.37
Blackrock Inc. 1809547 6.35
Redmile Group, LLC 1733189 6.08
State Street Corporation 1237497 4.34
Frazier Life Sciences Management, L.P. 988460 3.47
Jennison Associates LLC 724344 2.54
Lord, Abbett & Co. LLC 618458 2.17
Dimensional Fund Advisors LP 550806 1.93

ETF Dele, % Lønnsomhet for året, % Utbytte, %
Jacob Forward ETF 2.70262 43.033162930921 0.15284
Franklin Genomic Advancements Fund Franklin Genomic Advancements Fund 4.53775 15.500403847566 0.22433
First Trust Active Factor Small Cap ETF 0.0841 34.251150665961 1.61948
Avantis U.S. Equity ETF 0.00221 32.224830464267 1.59151
Virtus LifeSci Biotech Products ETF 1.46245 36.788704846892 0.13953
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.30479 24.74842126706 1.59225
ProShares Ultra Nasdaq Biotechnology 0.34659 51.697637072723 0.85651
BNY Mellon US Small Cap Core Equity ETF 0.23293 30.067895247333 1.75333
VictoryShares US Small Cap Volatility Wtd ETF 0.10182 30.077120822622 1.67818
VictoryShares US Discovery Enhanced Volatility Wtd ETF 0.10149 21.399562636676 1.67826
Dimensional U.S. Core Equity 2 ETF 0.01968 30.755198832543 1.47098
Dimensional US Core Equity Market ETF 0.01008 30.983243755928 1.40618
Dimensional U.S. Equity ETF 0.00632 31.530984204131 1.3557
Invesco Dorsey Wright SmallCap Momentum ETF 0.57748 33.912466843501 0.61241
Vanguard ESG U.S. Stock ETF 0.01 32.395678092399 1.26927
iShares ESG Aware MSCI USA Small-Cap ETF 0.04807 33.616398243045 1.49366
First Trust Multi Cap Growth AlphaDEX Fund 0.11915 41.560262822399 1.02425
Fidelity MSCI Health Care Index ETF 0.0587 13.390080209527 1.46057
First Trust US Equity Opportunities ETF 0.23204 46.431426287541 0.69524
Fidelity Small-Mid Multifactor ETF 0.15442 32.307692307692 1.59943
First Trust Nasdaq BuyWrite Income ETF 0.13262 7.2708653353815 0.92977
First Trust Nasdaq Pharmaceuticals ETF 0.54366 18.366517675742 2.19901
First Trust Small Cap Growth AlphaDEX Fund 0.56792 42.49956240154 1.22182
First Trust Small Cap Core AlphaDEX Fund 0.28692 34.000896106576 1.87983
Goldman Sachs Innovate Equity ETF 0.08413 29.658020073179 1.20987
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.05689 31.359936575053 1.41955
ProShares Hedge Replication ETF 0.02777 5.9237999659878 1.47892
Humankind US Stock ETF 0.01926 18.809430395549 1.99919
Invesco Nasdaq Biotechnology ETF 0.50883 28.578975171685 0.8565
iShares Morningstar Small-Cap ETF 0.10009 30.095066471445 1.60498
iShares Morningstar Small-Cap Growth ETF 0.19941 33.628071953382 0.72598
iShares Russell 2000 Growth ETF 0.33761 38.042556988 0.6026
iShares Russell 3000 ETF 0.00827 32.57283798366 1.43482
John Hancock Multifactor Small Cap ETF 0.44188 31.445966146007 1.54912
iShares Morningstar Small-Cap ETF 0.10009 391.25300933451 1.60498
iShares Morningstar Small-Cap Growth ETF 0.19941 680.05582339508 0.72598
SPDR S&P Kensho New Economies Composite ETF 0.10429 31.133671742809 0.88486
Direxion Daily S&P Biotech Bull 3x Shares 0.64346 4067.9190751445 0.25924
First Trust Multi-Manager Small Cap Opportunities ETF 0.27344 48.514285714286 0.31756
SPDR S&P 1500 Momentum Tilt ETF 0.01375 38.251249368151 1.12176
Invesco Russell 2000 Dynamic Multifactor ETF 0.12351 23.041237113402 1.64004
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.02867 35.452103849597 1.75869
Invesco S&P SmallCap Health Care ETF 3.24661 27.32109603618 0.41696
Invesco Dorsey Wright Healthcare Momentum ETF 1.8811 34.33734939759 0.12263
Invesco S&P SmallCap 600 Revenue ETF 0.00787 30.924461412599 1.94562
ProShares Ultra SmallCap600 0.24667 49.800399201597 1.83727
Schwab U.S. Small-Cap ETF 0.12925 34.281650071124 1.51433
Schwab U.S. Broad Market ETF 0.00878 32.5 1.43354
SPDR S&P 600 Small Cap Growth ETF 0.46611 34.267040149393 1.33495
SPDR S&P 600 Small Cap Value ETF 0.23566 29.161010046158 2.34209
AlphaMark Actively Managed Small Cap ETF 0.92564 41.147942804763 1.74611
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.1494 29.310344827586 1.66828
SPDR Portfolio MSCI Global Stock Market ETF 0.00004 23.600605143722 2.19607
SPDR Portfolio S&P 600 Small Cap ETF 0.34897 31.781914893617 1.84119
SPDR Portfolio S&P 1500 Composite Stock Market ETF 0.00881 31.619629696207 1.46083
Syntax Stratified SmallCap ETF 0.15893 13.508906292462 1.639
FlexShares Morningstar US Market Factor Tilt Index Fund 0.01563 32.205226109465 1.69572
Northern Lights Fund Trust IV 0.53119 36.85261707989 0.49246
Timothy Plan US Small Cap Core ETF 0.09547 30.162507436516 1.63049
ProShares UltraPro Russell2000 0.09866 89.821266282945 1.47873
Vanguard Small Cap Value ETF 0.07 32.677982659665 2.19419
Vanguard U.S. Momentum Factor ETF 0.11 45.845704753962 1.05834
Vanguard S&P Small-Cap 600 Growth ETF 0.5 30.308661092185 1.37064
Vanguard S&P Small-Cap 600 ETF 0.37 32.617736315612 1.89226
Vanguard S&P Small-Cap 600 Value ETF 0.25 29.525999744474 2.40883
Vanguard Russell 3000 ETF 0.01 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.36 39.350070246167 0.60264
Vanguard Russell 2000 ETF 0.18 35.648084105685 1.48801
Vanguard Extended Market ETF 0.07 39.61241360618 1.34786
Principal Healthcare Innovators ETF 0.51487 618.4964157054 0.8416
Future Tech ETF 0.51487 426.33969118983 0.8416



Veileder Stillingstittel Betaling Fødselsår
Mr. Krish S. Krishnan M.B.A., M.S. Founder, Chairman, President & CEO 1.07M 1965 (59 år)
Ms. Suma M. Krishnan Founder, President of R&D and Director 789.92k 1965 (59 år)
Ms. Kathryn A. Romano Executive VP & Chief Accounting Officer 528.87k 1982 (42 år)
Mr. John Karakkal Vice President of North American Sales & Marketing N/A
Mr. Josh Suskin Director of Human Resources & Operations N/A
Mr. Laurent Goux Senior VP & GM of Europe N/A
Mr. John Thomas General Counsel & Corporate Secretary N/A
Ms. Christine Wilson Head of U.S. Sales & Marketing N/A
Dr. Stephane Paquette Ph.D. Vice President of Corporate Development
Mr. David Chien Senior Vice President of Clinical Development

Adresse: United States, Pittsburgh. PA, 2100 Wharton Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.krystalbio.com